e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
Rationale of self-education in asthma therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cost-effectiveness analysis of asthma treatment strategies
A. Ulitina, Y. Ilkovich, N. Shklyarevich (St.Petersburg, Russian Federation)
Source:
Annual Congress 2008 - Rationale of self-education in asthma therapy
Session:
Rationale of self-education in asthma therapy
Session type:
Oral Presentation
Number:
4422
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Ulitina, Y. Ilkovich, N. Shklyarevich (St.Petersburg, Russian Federation). Cost-effectiveness analysis of asthma treatment strategies. Eur Respir J 2008; 32: Suppl. 52, 4422
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Comparative efficacy of the therapy strategies for the asthma control maintenance in real clinical practice
Source: Annual Congress 2011 - Asthma: control and treatment
Year: 2011
Cost-effectiveness analysis of a Home-based disease management intervention for patients with severe COPD alongside the COMET study.
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018
Pharmacological strategies for self-management of asthma exacerbations
Source: Eur Respir J 2006; 28: 182-199
Year: 2006
Early detection of asthma exacerbations and the use of action points for treatment decisions in self-management plans
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011
Cost analysis for patients with severe asthma receiving omalizumab treatment
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019
Cost-effectiveness of a Brazilian program for severe asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 442s
Year: 2006
Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK
Source: ERJ Open Res, 7 (1) 00480-2020; 10.1183/23120541.00480-2020
Year: 2021
Primary asthma prevention amongst children — A cost-effectiveness analysis in a decision-analytic framework
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012
Cost-utility analysis of a Home-based disease management intervention for patients with severe COPD in the COMET study.
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Year: 2018
Difficult-to-treat asthma : a multidimensional approach before considering targeted therapy
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019
Cost-effectiveness of eNO measurements in chronic asthma management
Source: Eur Respir J 2007; 30: Suppl. 51, 193s
Year: 2007
Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study
Source: Eur Respir J 2010; 35: 532-539
Year: 2010
The therapeutic strategies in severe and very severe COPD: a cost-efficacy analysis in Italy
Source: Eur Respir J 2006; 28: Suppl. 50, 31s
Year: 2006
Cost consequences of tiotropium plus existing therapy
versus
existing therapy alone following one year of treatment in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 5s
Year: 2001
Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD
Source: Annual Congress 2010 - Smoking related disorders and smoking cessation
Year: 2010
Pharmacoeconomic aspects of inhaled corticocteroids in the treatment of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 98s
Year: 2001
Cost implications for the introduction of omalizumab in to the management of severe chronic asthma in children
Source: Eur Respir J 2006; 28: Suppl. 50, 481s
Year: 2006
Recent trends in inhaled corticosteroid prescriptions and its impact on COPD management: an analysis of the KOLD/KOCOSS cohorts
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept